Lilly Sees More Dealmaking as GLP-1 Wins Expand Market
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Find out what items sell best for quick cash. Making informed decisions can help you earn money easily and efficiently.
21,850 articlesEli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
If you’re worried about crash artificial headlines in AI stocks, a simple, cost-efficient solution can help: diversif...
A high-profile moment on television can ripple through a star's bank account. This article dissects what the Barkley ...
As markets shift and inflation cools, retirees at 60 face a critical question: how much monthly income can a $1.1 mil...
CFO compensation rose about 8% in 2025 as long-term incentives surged last year—and long-term incentives now dominate...
As Micron Technology rides AI-driven memory demand, investors debate a bold forecast. Market models suggest a potenti...
CFOs are bullish about their own firms even as the broader economy slows, according to Deloitte's Q2 2026 CFO Signals...
Prices stay higher than a few years ago, eroding cash savings. A trio of ETFs—GLD, VTIP, and DBC—are positioned to he...
A new MLP income ETF employs a covered call overlay to lift yield beyond AMLP, drawing attention from income-focused ...
SpaceX entering your retirement isn’t a single event. It could arrive in three distinct waves through the funds you a...
Memory names rebound sharply as AI-driven data-center demand returns, led by Western Digital and Seagate’s roughly 7%...
When blue-chip allocators signal interest in a landmark IPO, it reshapes how individual investors view the stock. Thi...